Crossway Technologies: MYPro Line for medical applications
Based in western France, Crossway Technologies has made a significant investment in a complete Mycronic line, marked by a major technological breakthrough with jet printing. This decision aims to create real industrial differentiation by bringing innovative and high-performance solutions to its manufacturing and integration processes.
Crossway Technologies : High-reliability medical productions
The company, with an aim for synergy and responsiveness, voluntarily shares the same premises with Creative Eurecom, a sister company and R&D lab specializing in the design, development, and industrialization of high-value-added electronic, mechanical, and fluid systems, particularly in the medical sector. An example of this collaboration is the home dialysis device by Physidia, which is still partly produced by Crossway Technologies, allowing patients with kidney failure to maintain an active professional and social life.
Innovative solutions to meet the needs of the medical sector
"We have many new products in development and are actively collaborating with industrial and medical sector professionals to provide innovative solutions in various fields, such as 3D mammography and more recently, liquid ventilation for hypothermia," explains Mr. Houdou, President of Crossway Technologies. "After a thorough analysis of various suppliers, we opted for the comprehensive solution provided by Mycronic. Their Jet Printer MY700 is the only technology offering a jet capacity of 1,000,000 points per hour, while eliminating issues related to the solder paste process, commonly found in screen printing machines."
Photo: Michel Houdou presenting the dialysis machine production line.
Photo: Standing in front of the new Mycronic SMT line (MY700 Jet Printer, MYPro A40DX17, 3D AOI MYPro I51, conveyors), from left to right: Cyrille Bidet (General Manager of Mycronic France), Yvon Monot (Sales Engineer Mycronic France), Solenne Grandsire (General Manager of Crossway Technologies), Michel Houdou (President of Crossway Technologies).
Additionally, the company has chosen the latest generation MYPro A40 DX17 pick-and-place machine, which achieves an impressive speed of 59,000 components per hour. Thanks to its new MX7 pick-and-place technology, this machine can place over 97% of components with its high-speed head. Connected to the MYTower 7+ intelligent storage system, this Mycronic solution further optimizes productivity by ensuring a continuous supply of components to the pick-and-place machine, significantly reducing production downtime due to hiccups in component supply.
MYTower 7+ storage tower positioned close to the assembly line for quick component supply.
After a thorough analysis of various suppliers, we opted for Mycronic's comprehensive solution. Their MY700 Jet Printer is the only technology offering a printing capacity of 1,000,000 points per hour, while eliminating issues related to the solder paste process, commonly found in screen printing machines.
Artificial Intelligence at the service of quality
To ensure consistent quality, Crossway Technologies has also integrated the MYPro I51 3D AOI inspection machine, equipped with artificial intelligence. This technology helps reduce false defects and optimize operator decisions, thus decreasing reliance on human intervention and ensuring more precise quality control. "We seek efficient and reliable solutions where technology and human expertise combine to maintain a constant and impeccable level of quality for our clients," explains Solenne Grandsire, General Manager. "The medical field leaves no room for error, and we have the same high standards for our suppliers. In this context, Mycronic solutions meet our expectations."
Photo: At the end of production line: the new MYPro I51 3D AOI with AI-assisted programming and review.
With this strategic investment, Crossway Technologies affirms its commitment to staying at the forefront of innovation and contributing to the development of advanced medical solutions, while also enhancing its industrial competitiveness.